Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable receptor antagonist activity and transforming growth factor beta binding activity. Acts upstream of or within several processes, including muscle cell development; roof of mouth development; and transforming growth factor beta receptor signaling pathway. Located in extracellular space. Is expressed in several structures, including central nervous system; genitourinary system; limb; liver; and spleen. Orthologous to human WFIKKN2 (WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.